CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma

Published:2024-02-13 Issue:1 Volume:16 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Zhu Dan¹,Hadjivassiliou Haralambos¹,Jennings Catherine¹,Mikolon David¹,Ammirante Massimo²,Acharya Sharmistha¹,Lloyd Jon¹,Abbasian Mahan¹,Narla Rama Krishna²,Piccotti Joseph R.³,Stamp Katie³,Cho Ho¹,Hariharan Kandasamy¹

Affiliation:

1. Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USA

2. Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, CA, USA

3. Department of Nonclinical Development, Bristol Myers Squibb, San Diego, CA, USA

Funder

no funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2024.2310248

Reference51 articles.

1. The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications

2. MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION

3. Functions and molecular mechanisms of the CD47–SIRPα signalling pathway

4. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion

5. Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction;mAbs;2024-05-12

2. In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies;mAbs;2024-03-27